Association between systemic immune-inflammatory markers and the risk of moyamoya disease: a case-control study

Association between systemic immune-inflammatory markers and the risk of moyamoya disease: a case-control study

AbstractBackground:Systemic immune-inflammatory markers such as neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR) and systemic immune-inflammatory index (SII) are associated with the prognosis of many cardiovascular and neoplastic diseases....

Full description

Bibliographic Details
Main Authors:	Wei Liu, Chenglong Liu, Xiaofan Yu, Yuanren Zhai, Qiheng He, Junsheng Li, Xingju Liu, Xun Ye, Qian Zhang, Rong Wang, Yan Zhang, Peicong Ge, Dong Zhang
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2023-12-01
Series:	Annals of Medicine
Subjects:	Systemic immune-inflammatory markers moyamoya disease neutrophil-to-lymphocyte ratio systemic immune-inflammatory index Suzuki stage
Online Access:	https://www.tandfonline.com/doi/10.1080/07853890.2023.2269368

Similar Items

Clinical value of the systemic immune-inflammation index in moyamoya disease
by: Erheng Liu, et al.
Published: (2023-04-01)

Association of circulating branched-chain amino acids with risk of moyamoya disease
by: Chaofan Zeng, et al.
Published: (2022-09-01)

Gut microbiota in adults with moyamoya disease: characteristics and biomarker identification
by: Xiaofan Yu, et al.
Published: (2023-10-01)

High Level of Serum Complement C3 Expression is Associated with Postoperative Vasculopathy Progression in Moyamoya Disease
by: Wang MJ, et al.
Published: (2024-03-01)

Correlation of Serum N-Acetylneuraminic Acid with the Risk of Moyamoya Disease
by: Chenglong Liu, et al.
Published: (2023-06-01)

Plasma urea cycle metabolite levels and the risk of moyamoya disease
by: Xiaofan Yu, et al.
Published: (2023-07-01)

Association between methionine sulfoxide and risk of moyamoya disease
by: Junsheng Li, et al.
Published: (2023-04-01)

Serum Kynurenic Acid and Kynurenine Are Negatively Associated with the Risk of Adult Moyamoya Disease
by: Xiaofan Yu, et al.
Published: (2022-11-01)

Hyperhomocysteinemia Is a Predictor for Poor Postoperative Angiogenesis in Adult Patients With Moyamoya Disease
by: Qiheng He, et al.
Published: (2022-06-01)

Circulating choline pathway nutrients and risk of moyamoya disease
by: Peicong Ge, et al.
Published: (2022-08-01)

Circulating Inflammatory Cytokine Associated with Poor Prognosis in Moyamoya Disease: A Prospective Cohort Study
by: Wei Liu, et al.
Published: (2023-01-01)

Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio in Patients With Newly Diagnosed Moyamoya Disease: A Cross-Sectional Study
by: Wenyuan Ma, et al.
Published: (2021-11-01)

The Values of Systemic Immune-Inflammation Index and Neutrophil–Lymphocyte Ratio in the Localized Prostate Cancer and Benign Prostate Hyperplasia: A Retrospective Clinical Study
by: Shuo Wang, et al.
Published: (2022-01-01)

Characterization of Immune Checkpoint Inhibitor-Related Cardiotoxicity in Lung Cancer Patients From a Rural Setting
by: Melissa Y.Y. Moey, MD, MSc, et al.
Published: (2020-09-01)

Angiographic Outcomes of Direct and Combined Bypass Surgery in Moyamoya Disease
by: Peicong Ge, et al.
Published: (2019-12-01)

Association between inflammation markers and all-cause mortality in critical ill patients with atrial fibrillation: Analysis of the Multi-Parameter Intelligent Monitoring in Intensive Care (MIMIC-IV) database
by: Qian Li, et al.
Published: (2024-04-01)

Predictive Value of Systemic Immune-inflammation Index in Determining Mortality in COVID-19 Patients
by: Karaaslan Tahsin, et al.
Published: (2022-08-01)

A practical nomogram based on systemic inflammatory markers for predicting portal vein thrombosis in patients with liver cirrhosis
by: Yueyi Xing, et al.
Published: (2022-12-01)

Postoperative collateral formation after indirect bypass for hemorrhagic moyamoya disease
by: Peicong Ge, et al.
Published: (2020-01-01)

Association of inflammatory markers with survival in patients with advanced gastric cancer treated with immune checkpoint inhibitors combined with chemotherapy as first line treatment
by: Mingyu Wan, et al.
Published: (2022-10-01)

Identification of immune-infiltrated hub genes as potential biomarkers of Moyamoya disease by bioinformatics analysis
by: Fa Jin, et al.
Published: (2022-02-01)

The Values of Systemic Immune-Inflammation Index and Neutrophil–Lymphocyte Ratio in Predicting Biochemical Recurrence in Patients With Localized Prostate Cancer After Radical Prostatectomy
by: Shuo Wang, et al.
Published: (2022-06-01)

Increased neutrophil–lymphocyte ratio predicts recurrence in patients with well-differentiated pancreatic neuroendocrine neoplasm based on the 2017 World Health Organization classification
by: Takayuki Miura, et al.
Published: (2021-03-01)

Nonalcoholic fatty liver disease is an independent risk factor for ischemic stroke after revascularization in patients with Moyamoya disease: a prospective cohort study
by: Bojian Zhang, et al.
Published: (2024-03-01)

Higher levels of systemic immune-inflammatory index are associated with the prevalence of gallstones in people under 50 years of age in the United States: a cross-sectional analysis based on NHANES
by: Chunli Meng, et al.
Published: (2024-01-01)

Prognostic value of systemic inflammatory markers in ovarian Cancer: a PRISMA-compliant meta-analysis and systematic review
by: Ying Zhu, et al.
Published: (2018-04-01)

Predictive Value of Pretreatment Lymphocyte-to-Monocyte Ratio and Platelet-to-Lymphocyte Ratio in the Survival of Nasopharyngeal Carcinoma Patients
by: Chen Y, et al.
Published: (2021-11-01)

Different subtypes of collateral vessels in hemorrhagic moyamoya disease with p.R4810K variant
by: Peicong Ge, et al.
Published: (2020-08-01)

Risk factors for postoperative ischemic complications in pediatric moyamoya disease
by: Xiaofeng Deng, et al.
Published: (2021-06-01)

Role of inflammatory factors in prediction of Gleason score and its upgrading in localized prostate cancer patients after radical prostatectomy
by: Shuo Wang, et al.
Published: (2023-01-01)

Hypo-high density lipoproteinemia is a predictor for recurrent stroke during the long-term follow-up after revascularization in adult moyamoya disease
by: Xiaofan Yu, et al.
Published: (2022-07-01)

Moyamoya disease associated with ankylosing spondylitis in a 9-year-old child: a case report
by: Fan Yang, et al.
Published: (2017-07-01)

Moyamoya hastalığında fonksiyonel iyileşme
by: Mehmet DURAY, et al.
Published: (2017-09-01)

Neutrophil to Lymphocyte Ratio as a Predictive Factor for Evaluation of Outcome in Critically Ill Patients
by: Maryam Alizadeh Chamkhaleh, et al.
Published: (2020-12-01)

The Effect of Virus-Specific Vaccination on Laboratory Infection Markers of Children with Acute Rotavirus-Associated Acute Gastroenteritis
by: Omer Okuyan, et al.
Published: (2023-03-01)

Clinical Management of Moyamoya Patients
by: Isabella Canavero, et al.
Published: (2021-08-01)

Doença de Moyamoya
by: Kelin Cristine Martin, et al.
Published: (2011-04-01)

Complete Blood Count-Derived Inflammatory Markers Changes in Dogs with Chronic Inflammatory Enteropathy Treated with Adipose-Derived Mesenchymal Stem Cells
by: José Ignacio Cristóbal, et al.
Published: (2022-10-01)

Effect of Antipsychotic Treatment on Neutrophil-to-Lymphocyte Ratio during Hospitalization for Acute Psychosis in the Course of Schizophrenia—A Cross-Sectional Retrospective Study
by: Bartosz Dawidowski, et al.
Published: (2021-12-01)

Impact of high neutrophil‐to‐lymphocyte ratio on survival in hospitalized cancer patients with COVID‐19
by: Fernando A. Díaz‐Couselo, et al.
Published: (2023-03-01)